These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1296004)
1. The economics of hypertension control: some basic issues. Maynard A J Hum Hypertens; 1992 Dec; 6(6):417-20. PubMed ID: 1296004 [No Abstract] [Full Text] [Related]
2. Relative costs of antihypertensive drug treatment. Strasser T J Hum Hypertens; 1992 Dec; 6(6):489-94. PubMed ID: 1296015 [No Abstract] [Full Text] [Related]
3. Economics and the treatment of hypertension. Swales JD J Hypertens; 1995 Dec; 13(12 Pt 1):1357-61. PubMed ID: 8866897 [No Abstract] [Full Text] [Related]
4. Cost of hypertension treatment and the price of health. Menard J; Cornu P; Day M J Hum Hypertens; 1992 Dec; 6(6):447-58. PubMed ID: 1296008 [No Abstract] [Full Text] [Related]
5. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies]. Rorive G; Delporte JP Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395 [TBL] [Abstract][Full Text] [Related]
6. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension]. Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623 [No Abstract] [Full Text] [Related]
7. Government guidelines for treatment of hypertension. Spence JD Am J Hypertens; 1995 May; 8(5 Pt 1):541. PubMed ID: 7662234 [No Abstract] [Full Text] [Related]
9. Cost effective analyses in the treatment of high blood pressure. Fletcher A J Hum Hypertens; 1992 Dec; 6(6):437-45. PubMed ID: 1296007 [No Abstract] [Full Text] [Related]
10. Compliance with antihypertensive therapy: raising the bar of expectations. Rudd P Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995 [TBL] [Abstract][Full Text] [Related]
11. Are there unintended consequences of step-therapy programs? Cox ER; Seiz BJ Am J Manag Care; 2009 Sep; 15(9):654, 656; author reply 656. PubMed ID: 19747030 [No Abstract] [Full Text] [Related]
12. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Caro JJ; Lee K Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167 [No Abstract] [Full Text] [Related]
13. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee. Ménard J Am J Hypertens; 1994 Oct; 7(10 Pt 1):877-85. PubMed ID: 7826550 [TBL] [Abstract][Full Text] [Related]
14. Health economic issues and the future treatment and management of hypertension. Giles TD AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589 [No Abstract] [Full Text] [Related]
15. Angiotensin receptor blockers: impact on costs of care. Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456 [TBL] [Abstract][Full Text] [Related]
16. Hypertension, a health economics perspective. Alcocer L; Cueto L Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):147-55. PubMed ID: 19124418 [TBL] [Abstract][Full Text] [Related]
18. [Comment on IOWiG report plan. A medical decision may not be replaced]. Vorstand der Deutschen Hochdruckliga E.V MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705 [No Abstract] [Full Text] [Related]